Rajeev Nair

In the latest issue of IBI Journal, Sarah McAliskey from Almac Clinical Services shares invaluable insights on leveraging technology and expertise to protect clinical trial supply. Her expertise highlights the critical impact of these practices on the pharmaceutical industry. Don't miss her feature on pages 56-58! Read more here:https://hubs.li/Q031G_0N0

33

1 Comment

"The spotlight on HCP and HCO spend disclosure underscores a new era of mandatory transparency within the life sciences industry." - Chapter 1, co-authored by Brian Fittipaldi, Director of Operations, Aggregate Spend and Andy Parks, Vice President of Compliance, explores the intricacies of Sunshine Transparency and Aggregate Spend, offering essential strategies for life sciences manufacturers. Unlock the insights now and stay ahead in compliance.  https://bit.ly/3Lchsya

11

Register now: https://loom.ly/V7hvN_g Join experts from AssistRx and MMIT (Managed Markets Insight & Technology) on Dec. 3 at 1 p.m. ET to discover the strategies life sciences organizations can use to alleviate copay program disruptions in 2025. During the webinar, we’ll detail how the perfect blend of tech and talent can help address recent payer activity, including new payer utilization management strategies and the changing copay accumulator and maximizer landscape. Can’t make it live? Request a recording when you sign up to view on your schedule. #InformedAccess #ImprovedOutcomes

15

In the latest issue of Contract Pharma, Tunnell Consulting, Inc.’s Lisa Cozza and Valerie Myers, SHRM-SCP highlight the rise of fractional staffing in life sciences and biotech. Companies are increasingly using flexible, project-specific talent to address the growing complexity of the industry. From regulatory expertise to quality assurance, fractional staffing offers cost-effective, scalable solutions, but seamless integration is key. This involves careful skills assessments, cultural fit, knowledge transfer, and setting clear expectations. Is your company exploring fractional staffing to stay agile? What challenges have you encountered? #LifeSciences #Biotech #FractionalStaffing #Pharma Contract Pharma

30

Are you ready to navigate the complexities of the life sciences industry and drive growth? Join our live webinar, where Deloitte experts will share insights into overcoming regulatory challenges, optimizing margins, and harnessing innovation through effective Enterprise Business Planning (EBP). In this session, you'll learn: 🤝 Key trends shaping the industry: Specialty drugs, regulatory hurdles, new technologies, and more. 🔎 Introduction to EBP: Unify your strategy and operations for a cohesive financial outlook. 👥 Achieving cross-functional alignment: Integrate efforts across commercial, supply chain, and finance. 📈 Real-life success story: How a global biopharma leader used EBP for seamless production planning. 🚀 Practical guidance: Initiate EBP in your organization with a live demo and actionable steps. #LifeSciences #AnaplanAdvisorySeries #Deloitte #EBP

36

1 Comment

Connecting the systems involved in the lifecycle management of clinical supplies closes the gap between the physical and digital supply chain, reducing the effort required to manage trial data and lowering overall risk. Having access to real-time, quality data enables sponsors to make timely and informed decisions. Read more today from Abby Sener, PMP, Almac One Manager at IXRS®3 by Almac Clinical Technologies in her latest feature in Applied Clinical Trials Magazine: https://hubs.li/Q02Q4mDl0

15

Biopharma Layoffs: Navigating Challenges and Industry Implications The biopharma industry has seen significant shifts recently, with layoffs impacting numerous companies and professionals. Understanding the causes, challenges, and broader implications is crucial for industry resilience and future growth. Read more on BioSpectrum Jobs : https://lnkd.in/dhkSQZ5u #biopharma #layoffs #industryinsights #BioSpectrumJobs #jobmarket #pharma #biotechnology #careers #jobcuts #pharmalayoffs

2

Free Webinar Alert: Data-Driven PPM resource management for life sciences Join us for an exclusive webinar designed to revolutionize your approach to project and portfolio management (PPM) in the life sciences industry. Dave Penndorf, our PPM Advisor and Himanshu A. our PPM practice lead, will share the critical role of data and analytics in driving decision-making when it comes to PPM resource management. Why should you attend?  - Significance of data-driven PPM resource management in life sciences  - Real-world applications and practical use cases  - Ways to leverage data and analytics   - Pre-requisites for achieving data-driven PPM success  - Exclusive insights from a recent benchmarking study Register now: https://lnkd.in/diMqrSaQ    #i2econsulting #Webinar #LifeSciences #PPM #StrategicPlanning #DataDrivenDecisionMaking #ProjectManagement #PortfolioManagement

30

Preparing to launch a new #pharma product? Don't miss our latest Thought Leadership post on #distribution strategy. Archbow Director and distribution expert Michelle Zeigler details four critical considerations for a successful #3PL launch. #consultant #biotech

8

⏰ TODAY ⏰ Register for the PMSA & McKesson Compile: Charting New Paths: Data and Analytics in the Evolving Oncology Landscape Date: Wednesday, October 16th at 12:00pm EST Registration Link: https://lnkd.in/eymbBj8C Summary: Advances in science and technology are enabling a new era in oncology diagnosis and treatment. At the same time, the data landscape is changing, influenced by social and government pressures as well as patients wanting to take more control of their own healthcare data. To deliver therapies most effectively to the patients that need them, oncology brands must understand how to best use the data available to stay ahead of the curve and understand the evolving oncology market. Join Tom Morrison, Director of Real-World Data and Advanced Analytics at McKesson Compile, and Edward Stelmack, Senior Director of Customer Success at McKesson Compile, to delve into how to navigate challenges posed by this evolving data landscape on the oncology market. In this webinar, we will review best practices for evaluating markets, identifying treatment-ready patients, and targeting healthcare professionals. Specifically, we’ll cover how to use real-world data and analytics to: - Decipher emerging trends in the oncology market - Up-level your patient journey analyses to find the right patients earlier - Remove the gaps in understanding where and how patients receive therapy Don't miss this opportunity to gain valuable insights and practical strategies to thrive in this dynamic space

4

Faster FDA approval through Real-World Evidence? Absolutely! FDA is incorporating RWE into regulatory decisions, helping pharmaceutical companies streamline the approval process. Learn how RWE can benefit your product's journey. #FDAApproval #RWE #CommercialStrategy #FacetLifeSciences https://hubs.ly/Q02Vb54y0

5

Wilfred Mascarenhas, Executive Director of Eli Lilly and Company, joins fellow industry experts in hosting BioPhorum IT Digital and Data’s webinar on 10 December 15:00-16:30 GMT, where attendees will hear key highlights and recommendations from our publication ‘Managing data as a product for digital transformation in the pharmaceutical industry’.     You can register here: https://lnkd.in/e-gb5qKT     Wildred shares, “There is no one-size-fits-all when it comes to figuring out how to enable and resource building of the data products. At Lilly, we’ve used a hybrid approach. The definition, ownership and governance of the data products is done by the various business functions and process owners (data mesh approach), while the build of the data products, GMP validation, etc. is done centrally by IT (data fabric approach).”      #pharma #dataproducts

21

1 Comment

New Blog Post Alert! Our latest blog highlights how Prescient supported a mid-size, oncology-focused pharmaceutical company in transforming its evidence-generation capabilities. This post showcases how proactive, strategic planning can enable impactful evidence generation that drives real-world success. Read more: https://bit.ly/3YY7Tef #Biopharma #EvidenceGeneration #OrganizationalTransformation #Oncology

19

Staying ahead of regulatory changes is essential for pharmaceutical companies to thrive in the ever-evolving healthcare landscape. Our team of experts recently hosted a webinar to share strategic considerations around the Inflation Reduction Act and tips to effectively navigate evolving regulatory implementations. Watch: https://ow.ly/p1kc50RqLh1

24

Check out our latest article by Evan Hansberry that discusses reasons why biotechnology and pharmaceutical companies should consider establishing their Safety function earlier in the drug development process. Read the full article on our website: https://ow.ly/CaU550SohfA #drugsafety #pharmacovigilance #biotechnology #pharmaceuticals #prestigescientific

3